artemether has been researched along with Cognitive Decline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cai, QC; Cao, C; Chen, DM; Chen, Y; Cong, L; Gao, CW; Hou, C; Li, HJ; Liu, HY; Wang, TZ; Xue, ZZ; Yang, JL; Yao, Q; Zhang, Y; Zhu, QS | 1 |
1 other study(ies) available for artemether and Cognitive Decline
Article | Year |
---|---|
Artemether Attenuates Aβ25-35-Induced Cognitive Impairments by Downregulating Aβ, BACE1, mTOR and Tau Proteins.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Artemether; Aspartic Acid Endopeptidases; Cognitive Dysfunction; Peptide Fragments; Rats; tau Proteins; TOR Serine-Threonine Kinases | 2021 |